Literature DB >> 7295999

The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study.

S H Goodnight, W S Harris, W E Connor.   

Abstract

The rarity of atherosclerotic vascular disease and a mild bruising tendency in Greenland Eskimos has been linked to their ingestion of omega 3 fatty acids contained in foods obtained from the sea. Previous studies have shown that feeding salmon oil to normal volunteers resulted in reductions of plasma cholesterol and triglycerides. We wished to learn whether salmon oil feeding would result in the incorporation of omega 3 fatty acids into platelets and whether platelet function or platelet-vessel interaction would be altered. Diets containing salmon oils led to the incorporation of eicosapentaenoic acid (C20:5 omega 3) into platelets (6.1%) with a reduction in arachidonic acid (C20:4 omega 6). The ratio of C20:5/C20:4 increased from 0.0045 on the control diet to 0.3 on the salmon diet. Bleeding times were prolonged (from 6.75 to 10 min, p less than 0.005), platelet retention on glass beads was mildly reduced (from 89% to 78%, p less than 0.0005), and platelet aggregation in response to dilute concentrations of ADP was inhibited in the subjects ingesting the salmon oil. We conclude that in normal subjects dietary omega 2 fatty acids derived from salmon oil are incorporated into platelet phospholipids and that these changes are accompanied by alterations in bleeding time and platelet function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295999

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  Effects of a fish oil enriched diet on aspirin intolerant asthmatic patients: a pilot study.

Authors:  C Picado; J A Castillo; N Schinca; M Pujades; A Ordinas; A Coronas; A Agusti-Vidal
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

2.  Adverse events associated with interactions with dietary and herbal supplements among inpatients.

Authors:  Ilana Levy; Samuel Attias; Eran Ben-Arye; Lee Goldstein; Elad Schiff
Journal:  Br J Clin Pharmacol       Date:  2016-11-25       Impact factor: 4.335

3.  Potential drug interactions with dietary and herbal supplements during hospitalization.

Authors:  Ilana Levy; Samuel Attias; Eran Ben-Arye; Lee Goldstein; Elad Schiff
Journal:  Intern Emerg Med       Date:  2016-10-05       Impact factor: 3.397

Review 4.  Absorption and transport of fat in mammals with emphasis on n-3 polyunsaturated fatty acids.

Authors:  G J Nelson; R G Ackman
Journal:  Lipids       Date:  1988-11       Impact factor: 1.880

5.  N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients' daytime blood pressure, and improves inflammatory status.

Authors:  Keren Doenyas-Barak; Sylvia Berman; Ramzia Abu-Hamad; Ahuva Golik; Naomi Rahimi-Levene; Shai Efrati
Journal:  Eur J Clin Pharmacol       Date:  2012-02-25       Impact factor: 2.953

6.  Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers.

Authors:  Alison H Keenan; Theresa L Pedersen; Kristi Fillaus; Mark K Larson; Gregory C Shearer; John W Newman
Journal:  J Lipid Res       Date:  2012-05-24       Impact factor: 5.922

7.  Risk of post-procedural bleeding in children on intravenous fish oil.

Authors:  Prathima Nandivada; Lorenzo Anez-Bustillos; Alison A O'Loughlin; Paul D Mitchell; Meredith A Baker; Duy T Dao; Gillian L Fell; Alexis K Potemkin; Kathleen M Gura; Ellis J Neufeld; Mark Puder
Journal:  Am J Surg       Date:  2016-12-01       Impact factor: 2.565

8.  NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements.

Authors:  Kathryn Williamson; Emmanuel Hatzakis
Journal:  J Vis Exp       Date:  2017-05-01       Impact factor: 1.355

9.  Inhibitory effect of stearidonic acid (18:4 n-3) on platelet aggregation and arachidonate oxygenation.

Authors:  V Kockmann; D Spielmann; H Traitler; M Lagarde
Journal:  Lipids       Date:  1989-12       Impact factor: 1.880

10.  EPA, but not DHA, decreases mean platelet volume in normal subjects.

Authors:  Yongsoon Park; William Harris
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.